Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitatime-L is a combination digestive enzyme and probiotic supplement developed and marketed by Intra Life. Formulated as an oral capsule, it contains fungal diastase (amylase) and lactic acid bacillus spores (Lactobacillus sporogenes). Fungal diastase aids in the digestion of dietary carbohydrates and starches by catalyzing their breakdown into simpler, easily absorbable sugars. Lactic acid bacillus spores act as a probiotic, germinating in the intestine to restore and maintain a healthy balance of beneficial gut microflora. Vitatime-L is indicated for the management of indigestion, dyspepsia, abdominal bloating, flatulence, gas, loss of appetite, and general digestive discomfort.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vitatime-L.